| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Endocrinology and Metabolism, Vol 269, Issue 3 E516-E523, Copyright © 1995 by American Physiological Society
ARTICLES |
O. Peroni, V. Large and M. Beylot
Institut National de la Sante et de la Recherche Medicale Unite 197, Faculte de Medecine Alexis Carrel, Lyon, France.
We tested the validity of the use of [2-13C]glycerol and of the mass isotopomer distribution analysis of glucose for measuring gluconeogenesis in vitro and in vivo. When isolated rat livers (starved for 48 h) were infused with labeled glycerol without or with lactate+pyruvate, gluconeogenesis accounted for > 90% of glucose production. When glucose was added to the infusate so that glucose produced by the liver represented only 80 or 45% of total glucose output, this dilution could be calculated from the mass isotopomer distribution of glucose. When postabsorptive and starved rats were infused with [2-13C]glycerol, gluconeogenesis accounted for 54 +/- 2 and 89 +/- 1%, respectively, of glucose production. However, accurate measures could be obtained, particularly in postabsorptive rats, only with high tracer infusion rates (representing > or = 50% of endogenous glycerol production rate). In both groups of rats, these infusion rates resulted in an increase in total glycerol turnover rate and gluconeogenesis from glycerol. In addition, hepatic concentration of glycerol 3-phosphate was increased. In conclusion, [2-13C]glycerol infusion and mass isotopomer distribution analysis of glucose appear to be useful methods for studies of gluconeogenesis in vitro and in vivo; however, accurate measurements in vivo can be obtained only at the expense of some perturbation of the metabolic pathway studied.
This article has been cited by other articles:
|
|
 |
|
  T. Stellingwerff, M. J. Watt, G. J. F. Heigenhauser, and L. L. Spriet Effects of reduced free fatty acid availability on skeletal muscle PDH activation during aerobic exercise Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E589 - E596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kuriyama, I. Shimomura, K. Kishida, H. Kondo, N. Furuyama, H. Nishizawa, N. Maeda, M. Matsuda, H. Nagaretani, S. Kihara, et al. Coordinated Regulation of Fat-Specific and Liver-Specific Glycerol Channels, Aquaporin Adipose and Aquaporin 9 Diabetes, October 1, 2002; 51(10): 2915 - 2921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Shah, A. Vella, A. Basu, R. Basu, A. Adkins, W. F. Schwenk, C. M. Johnson, K. S. Nair, M. D. Jensen, and R. A. Rizza Effects of Free Fatty Acids and Glycerol on Splanchnic Glucose Metabolism and Insulin Extraction in Nondiabetic Humans Diabetes, February 1, 2002; 51(2): 301 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Croset, F. Rajas, C. Zitoun, J.-M. Hurot, S. Montano, and G. Mithieux Rat Small Intestine Is an Insulin-Sensitive Gluconeogenic Organ Diabetes, April 1, 2001; 50(4): 740 - 746. [Abstract] [Full Text]
|
|
|
|
|
|
W. Wang, A. Basinger, R. A. Neese, M. Christiansen, and M. K. Hellerstein Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E50 - E59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Haymond and A. L. Sunehag The reciprocal pool model for the measurement of gluconeogenesis by use of [U-13C]glucose Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E140 - E145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Puchowicz, I. R. Bederman, B. Comte, D. Yang, F. David, E. Stone, K. Jabbour, D. H. Wasserman, and H. Brunengraber Zonation of acetate labeling across the liver: implications for studies of lipogenesis by MIDA Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1022 - E1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Diraison, V. Large, C. Maugeais, M. Krempf, and M. Beylot Noninvasive tracing of human liver metabolism: comparison of phenylacetate and apoB-100 to sample glutamine Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E529 - E536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Previs, G. W. Cline, and G. I. Shulman A critical evaluation of mass isotopomer distribution analysis of gluconeogenesis in vivo Am J Physiol Endocrinol Metab, July 1, 1999; 277(1): E154 - E160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Hellerstein and R. A. Neese Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1146 - E1170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Q. Siler, R. A. Neese, M. P. Christiansen, and M. K. Hellerstein The inhibition of gluconeogenesis following alcohol in humans Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E897 - E907. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. Previs, P. T. Hallowell, K. D. Neimanis, F. David, and H. Brunengraber Limitations of the Mass Isotopomer Distribution Analysis of Glucose to Study Gluconeogenesis. HETEROGENEITY OF GLUCOSE LABELING IN INCUBATED HEPATOCYTES J. Biol. Chem., July 3, 1998; 273(27): 16853 - 16859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. J. Kurland, A. Alcivar, S. Bassilian, and W.-N. P. Lee Loss of [13C]Glycerol Carbon via the Pentose Cycle. IMPLICATIONS FOR GLUCONEOGENESIS MEASUREMENT BY MASS ISOTOPER DISTRIBUTION ANALYSIS J. Biol. Chem., November 17, 2000; 275(47): 36787 - 36793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. van Dijk, F. H. van der Sluijs, C. H. Wiegman, J. F. W. Baller, L. A. Gustafson, H.-J. Burger, A. W. Herling, F. Kuipers, A. J. Meijer, and D.-J. Reijngoud Acute Inhibition of Hepatic Glucose-6-phosphatase Does Not Affect Gluconeogenesis but Directs Gluconeogenic Flux toward Glycogen in Fasted Rats. A PHARMACOLOGICAL STUDY WITH THE CHLOROGENIC ACID DERIVATIVE S4048 J. Biol. Chem., July 6, 2001; 276(28): 25727 - 25735. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
